0

LYG-202

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP1175077254
CAS1175077-25-4
Molecular Weight438.52
Description≥98% (HPLC)
SolubilityDMSO: 2 mg/mL, clear (warmed)
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditions2-8°C
1

LYG-202 Exerts Antitumor Effect on PI3K/Akt Signaling Pathway in Human Breast Cancer Cells

Yue Zhao, Xiaoping Wang, Yang Sun, Yuxin Zhou, Yuehan Yin, Youxiang Ding, Zhiyu Li, Qinglong Guo, Na Lu

Apoptosis. 2015 Sep;20(9):1253-69.

PMID: 26153346

1

LYG-202 Inhibits Activation of Endothelial Cells and Angiogenesis Through CXCL12/CXCR7 Pathway in Breast Cancer

Kai Zhao, Yuyuan Yao, Xuwei Luo, Binyan Lin, Yujie Huang, Yuxin Zhou, Zhiyu Li, Qinglong Guo, Na Lu

Carcinogenesis. 2018 Apr 5;39(4):588-600.

PMID: 29390073

1

LYG-202 Inhibits the Proliferation of Human Colorectal Carcinoma HCT-116 Cells Through Induction of G1/S Cell Cycle Arrest and Apoptosis via p53 and p21(WAF1/Cip1) Expression

Wei Liu, Qinsheng Dai, Na Lu, Libin Wei, Jun Ha, Jingjing Rong, Rong Mu, Qidong You, Zhiyu Li, Qinglong Guo

Biochem Cell Biol. 2011 Jun;89(3):287-98.

PMID: 21491996

1

LYG-202, a New Flavonoid With a Piperazine Substitution, Shows Antitumor Effects in Vivo and in Vitro

Shi Zeng, Wei Liu, Fei-Fei Nie, Qing Zhao, Jing-Jing Rong, Jia Wang, Lei Tao, Qi Qi, Na Lu, Zhi-Yu Li, Qing-Long Guo

Biochem Biophys Res Commun. 2009 Aug 7;385(4):551-6.

PMID: 19481059

1

LYG-202, a Newly Synthesized Flavonoid, Exhibits Potent Anti-Angiogenic Activity in Vitro and in Vivo

Yan Chen, Na Lu, Yun Ling, Ling Wang, Qidong You, Zhiyu Li, Qinglong Guo

J Pharmacol Sci. 2010;112(1):37-45.

PMID: 20093787

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode